Patents by Inventor Mathilde Latil

Mathilde Latil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230158046
    Abstract: A composition including at least one phytoecdysone or at least one semi-synthetic derivative of a phytoecdysone, for use in mammals for preventing the loss of muscle strength during immobilisation. More particularly, a composition for use that includes 20-hydroxyecdysone or a semi-synthetic derivative of 20-hydroxyecdysone. Moreover, the composition for use includes a compound of general formula (I).
    Type: Application
    Filed: January 24, 2023
    Publication date: May 25, 2023
    Inventors: Pierre DILDA, Mathilde LATIL, René LAFONT, Stanislas VEILLET
  • Publication number: 20230128105
    Abstract: Disclosed are phytoecdysones and semisynthetic derivatives of phytoecdysones, intended to be used in treating impairment of the respiratory function in mammals, in particular in the context of a viral infection and more particularly during an infection by a coronavirus.
    Type: Application
    Filed: March 24, 2021
    Publication date: April 27, 2023
    Inventors: Pierre DILDA, René LAFONT, Stanislas VEILLET, Samuel AGUS, Waly DIOH, Serge CAMELO, Mathilde LATIL, Mounia CHABANE DE SAINT AUBIN, Cendrine TOURETTE
  • Publication number: 20230089459
    Abstract: Disclosed is chemical compounds C that are derivatives of norbixin and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease.
    Type: Application
    Filed: December 22, 2020
    Publication date: March 23, 2023
    Inventors: Laurence DINAN, René LAFONT, Pierre DILDA, Serge CAMELO, Valérie FONTAINE, Christine BALDUCCI, Elodie MONTEIRO, Louis GUIBOUT, Mathilde LATIL, José-Alain SAHEL, Stanislas VEILLET
  • Patent number: 11542295
    Abstract: The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: January 3, 2023
    Assignees: BIOPHYTIS, SORBONNE UNIVERSITÉ
    Inventors: Pierre Dilda, René Lafont, Mathilde Latil, Maria Serova, Onnik Agbulut, Stanislas Veillet
  • Publication number: 20220160732
    Abstract: Disclosed are 20-hydroxyecdysone and the derivatives thereof, intended for use in the treatment of a neuromuscular disease such as spinal muscular atrophy or amyotrophic lateral sclerosis, or more particularly in the treatment of a specific disorder of the motor neurons causing alterations in the muscular function occurring in the context of these neuromuscular diseases.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 26, 2022
    Inventors: Mathilde LATIL, Pierre DILDA, René LAFONT, Stanislas VEILLET
  • Publication number: 20220152060
    Abstract: Disclosed are phytoecdysones and the derivatives thereof, intended for use in the treatment of impaired lung function in mammals, in particular in the context of a neuromuscular disease and more particularly when the impaired lung function is linked to a deterioration of the mechanical properties of the lung tissue.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 19, 2022
    Inventors: Mathilde LATIL, Pierre DILDA, René LAFONT, Stanislas VEILLET
  • Publication number: 20210369735
    Abstract: A composition including at least one phytoecdysone or at least one semi-synthetic derivative of a phytoecdysone, for use in mammals for preventing the loss of muscle strength during immobilisation. More particularly, a composition for use that includes 20-hydroxyecdysone or a semi-synthetic derivative of 20-hydroxyecdysone. Moreover, the composition for use includes a compound of general formula (I).
    Type: Application
    Filed: February 20, 2019
    Publication date: December 2, 2021
    Inventors: Pierre DILDA, Mathilde LATIL, René LAFONT, Stanislas VEILLET
  • Publication number: 20200179407
    Abstract: The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 11, 2020
    Applicants: BIOPHYTIS, SORBONNE UNIVERSITE
    Inventors: Pierre DILDA, René LAFONT, Mathilde LATIL, Maria SEROVA, Onnik AGBULUT, Stanislas VEILLET
  • Patent number: 10076113
    Abstract: The present invention relates to methods for obtaining stem cells from mammalian cadavers, methods for obtaining or purifying stem cells from a sample likely to contain non-stem cells, methods of regeneration of injured tissues and methods of treatment.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: September 18, 2018
    Assignees: Institut Pasteur, Centre National De La Recherche Scientifique (C.N.R.S.)
    Inventors: Fabrice Chretien, Mathilde Latil, Shahragim Tajbakhsh
  • Publication number: 20170086453
    Abstract: The present invention relates to methods for obtaining stem cells from mammalian cadavers, methods for obtaining or purifying stem cells from a sample likely to contain non-stem cells, methods of regeneration of injured tissues and methods of treatment.
    Type: Application
    Filed: October 11, 2016
    Publication date: March 30, 2017
    Inventors: Fabrice CHRETIEN, Mathilde LATIL, Shahragim TAJBAKHSH
  • Patent number: 9499792
    Abstract: The present invention relates to methods for obtaining stem cells from mammalian cadavers, methods for obtaining or purifying stem cells from a sample likely to contain non-stem cells, methods of regeneration of injured tissues and methods of treatment.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: November 22, 2016
    Assignees: CENTRE NATIONAL DE LARECHERCHE SCIENTIFIQUE (C.N.R.S), INSTITUT PASTEUR
    Inventors: Fabrice Chretien, Mathilde Latil, Shahragim Tajbakhsh
  • Publication number: 20130149286
    Abstract: The present invention relates to methods for obtaining stem cells from mammalian cadavers, methods for obtaining or purifying stem cells from a sample likely to contain non-stem cells, methods of regeneration of injured tissues and methods of treatment.
    Type: Application
    Filed: June 3, 2011
    Publication date: June 13, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N., INSTITUT PASTEUR
    Inventors: Fabrice Chretien, Mathilde Latil, Shahragim Tajbakhsh